Asset Details
Do you wish to reserve the book?
Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and 11CPBR28
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and 11CPBR28
Do you wish to request the book?
Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and 11CPBR28
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and 11CPBR28
2017
Overview
Several lines of evidence are indicative of a role for immune activation in the pathophysiology of schizophrenia. Nevertheless, studies using positron emission tomography (PET) and radioligands for the translocator protein (TSPO), a marker for glial activation, have yielded inconsistent results. Whereas early studies using a radioligand with low signal-to-noise in small samples showed increases in patients, more recent studies with improved methodology have shown no differences or trend-level decreases. Importantly, all patients investigated thus far have been on antipsychotic medication, and as these compounds may dampen immune cell activity, this factor limits the conclusions that can be drawn. Here, we examined 16 drug-naive, first-episode psychosis patients and 16 healthy controls using PET and the TSPO radioligand [
11
C]PBR28. Gray matter (GM) volume of distribution (
V
T
) derived from a two-tissue compartmental analysis with arterial input function was the main outcome measure. Statistical analyses were performed controlling for both TSPO genotype, which is known to affect [
11
C]PBR28 binding, and gender. There was a significant reduction of [
11
C]PBR28
V
T
in patients compared with healthy controls in GM as well as in secondary regions of interest. No correlation was observed between GM
V
T
and clinical or cognitive measures after correction for multiple comparisons. The observed decrease in TSPO binding suggests reduced numbers or altered function of immune cells in brain in early-stage schizophrenia.
Publisher
Nature Publishing Group UK,Nature Publishing Group
